Summary
Background
The purpose of this study was to give an overview whether German students regularly use stimulants for enhancing their academic performance. Reasons associated with the use of these substances were explored. Moreover, gender differences were analyzed.
Methods
A cross-sectional survey study was performed analyzing a random sample of 1,053 students of different fields of study in Germany. Students were asked to complete an anonymous self-administered web-based survey containing questions on cognitive performance-enhancing substance use. We used statistical analyses, e.g. non-parametric tests to evaluate the data of our questionnaire.
Results
Among 1,053 students, 61 % responded to our questionnaire. The average age wasM = 24.58; 635 participants were female and 418 were male students. Total 1–13 % of the participating students have taken prescription stimulants (e.g. modafinil) or illicit drugs (e.g. cannabis) at least once in their lifetime. The most common reasons for taking stimulants were to support concentration, to relax and to increase alertness. We found significant gender differences with regard to frequency and reason for using performance-enhancing substances.
Conclusions
Our study results give an overview about the actual situation on frequency and reasons for taking performance-enhancing substances. Departments of Public Health should address this issue in national health debates and discussions. Based on our study findings health education programmes should be developed.
Zusammenfassung
Grundlagen
Medikamentöse Interventionen zur Steigerung des Leistungs- und Funktionsniveaus wurden in der letzten Zeit vermehrt in der Öffentlichkeit diskutiert. Generalisierbare, objektive Daten, die Auskunft über die Höhe des tatsächlichen Konsums von leistungssteigernden Mitteln geben, fehlen jedoch bislang. Ziel der vorliegenden Studie ist es daher, die Häufigkeit des Gebrauchs von leistungssteigernden Mitteln unter deutschen Studenten zu untersuchen. Ferner werden Gründe für den Gebrauch und Geschlechtsunterschiede fokussiert.
Methodik
Es wurde eine querschnittliche Online-Fragebogenstudie durchgeführt, in der 1.053 deutsche Studenten Auskunft über die Häufigkeit und Ursachen des Konsums von leistungssteigernden Mitteln geben sollten.
Ergebnisse
61 % der angeschriebenen Studenten beantworteten den Fragebogen. Das Durchschnittsalter war 24 Jahre; 635 Studentinnen und 418 Studenten beantworteten den Fragebogen 1–13 % der Studenten gaben an mindestens einmal in ihrem Leben verschreibungspflichtige Stimulantien (z. B. Modafinil) und/oder illegale Drogen (z. B. Cannabis) zur Leistungssteigerung oder Entspannung genommen zu haben. Die Hauptgründe für die Einnahme waren: Steigerung der Konzentration, Aufmerksamkeit und Entspannung. Es zeigten sich signifikante Geschlechtsunterschiede.
Schlussfolgerungen
Die Studiendaten geben einen Einblick über die aktuelle Situation des Konsums von Substanzen zur Leistungssteigerung und dessen Motivation. Institute der Gesundheitsversorgung sollten diese Situation weiterhin fokussieren und darauf aufbauend Aufklärungs- und Präventionsprogramme für Studenten an deutschen Universitäten entwickeln.
Similar content being viewed by others
References
Janus K, Amelung VE, Gaitanides M, Schwartz FW. German physicians “on strike”–shedding light on the roots of physician dissatisfaction. Health Policy. 2007;82:357–65.
Hensen P. The “Bologna Process” in European higher education: impact of bachelor’s and master’s degrees on German medical education. Teach Learn Med. 2011;22:142–7.
Jurkat HB, Richter L, Cramer M, Vetter A, Bedau S, et al. Depression and stress management in medical students. A comparative study between freshman and advanced medical students. Der Nervenarzt. 2011;82:646–52.
Himmelrath A. Wo ist hier das Druckventil? 2012.http://wwwspiegelde/karriere/berufsstart/0,1518,811920,00html. Accessed 21 Dec 2012.
Kinzelmann F, Töpper V. Berufseinstieg mit Bachelor-Schmalspurer oder Blitzstarter? 2012:1.http://wwwspiegelde/karriere/berufsstart/0,1518,810404,00html. Accessed 13 Dec 2012.
Meier S, Milz S, Krämer A. Gesund studieren Befragungsergebnisse des Gesundheitssurvey für Studierende. 2007.http://wwwtkde/centaurus/servlet/contentblob/48822/Datei/1855/Broschuere-Gesund-studierenpdf. Accessed 20 Dec 2007.
Thiel F, Blüthmann I, Lepa S, et al. Ergebnisse der Befragung der exmatrikulierten Bachelorstudierenden an der Freien Universität Berlin Sommersemester. 2007.http://wwwewi-psyfu-berlinde/einrichtungen/arbeitsbereiche/schulentwicklungsforschung/downloads/Exmatrikuliertenbefragung_2007pdf?1310986825. Accessed 17 Dec 2007.
Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44:60–6.
Franke AG, Christmann M, Bonertz C, Fellgiebel A, Huss M. Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry. 2011;44:331–8.
Normann C, Berger M. Neuroenhancement: status quo and perspectives. Eur Arch Psychiatry Clin Neurosci. 2008;258(Suppl 5):110–4.
Bostrom N, Sandberg A. Cognitive enhancement: methods, ethics, regulatory challenges. Sci Eng Ethics. 2009;15:311–41.
Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, et al. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci. 2004;5:421–5.
Forstl H. Neuro-enhancement. Brain doping. Nervenarzt. 2009;80:840–6.
Leonard BE, McCartan D, White J, King DJ. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol. 2004;19:151–80.
Outram SM. The use of methylphenidate among students: the future of enhancement? J Med Ethics. 2010;36:198–202.
Agay N, Yechiam E, Carmel Z, Levkovitz Y. Non-specific effects of methylphenidate (Ritalin) on cognitive ability and decision-making of ADHD and healthy adults. Psychopharmacology. 2010;210:511–9.
Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2004;55:1031–40.
Hirai N, Nishino S. Recent advances in the treatment of narcolepsy. Curr Treat Options Neurol. 2011;13:437–57.
Nehlig A. Is caffeine a cognitive enhancer? J Alzheimers Dis. 2010;20(Suppl 1):S85–94.
Lieberman HR. The effects of ginseng, ephedrine, and caffeine on cognitive performance, mood and energy. Nutr Rev. 2001;59:91–102.
Gledhill-Hoyt J, Lee H, Strote J, Wechsler H. Increased use of marijuana and other illicit drugs at US colleges in the 1990s: results of three national surveys. Addiction. 2000;95:1655–67.
Hall KM, Irwin MM, Bowman KA, Frankenberger W, Jewett DC. Illicit use of prescribed stimulant medication among college students. J Am Coll Health. 2005;53:167–74.
McNiel AD, Muzzin KB, DeWald JP, McCann AL, Schneiderman ED. The nonmedical use of prescription stimulants among dental and dental hygiene students. J Dent Educ. 2011;75:365–76.
Teter CJ, McCabe SE, Boyd CJ, Guthrie SK. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy. 2003;23:609–17.
Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;62:187–206.
Novak SP, Kroutil LA, Williams RL, Van Brunt DL. The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy. 2007;2:32.
Hotze TD, Shah K, Anderson EE, Wynia MK. “Doctor, would you prescribe a pill to help me…?” A national survey of physicians on using medicine for human enhancement. Am J Bioeth. 2011;11:3–13.
Brady KT, Gray KM, Tolliver BK. Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav. 2011;99:285–94.
Lynch G, Palmer LC, Gall CM. The likelihood of cognitive enhancement. Pharmacol Biochem Behav. 2011;99:116–29.
Lord S, Downs G, Furtaw P, Chaudhuri A, Silverstein A. Nonmedical use of prescription opioids and stimulants among student pharmacists. J Am Pharm Assoc (2003). 2009;49:519–28.
Weyandt LL, Janusis G, Wilson KG, Verdi G, Paquin G. Nonmedical prescription stimulant use among a sample of college students: relationship with psychological variables. J Atten Disord. 2009;13:284–96.
Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health. 2005;53:253–62.
Carroll BC, McLaughlin TJ, Blake DR. Patterns and knowledge of nonmedical use of stimulants among college students. Arch Pediatr Adolesc Med. 2006;160:481–5.
Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, et al. Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems? J Atten Disord. 2009;13:259–70.
Peterkin AL, Crone CC, Sheridan MJ, Wise TN. Cognitive performance enhancement: misuse or self-treatment? J Atten Disord. 2011;15:263–8.
Farah MJ, Haimm C, Sankoorikal G, Smith ME, Chatterjee A. When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study. Psychopharmacology. 2009;202:541–7.
Lanni C, Lenzken SC, Pascale A, Del Vecchio I, Racchi M, et al. Cognition enhancers between treating and doping the mind. Pharmacol Res. 2008;57:196–213.
McCabe SE, Teter CJ, Boyd CJ, Knight, JR, Wechsler H. Nonmedical use of prescription opioids among U.S. college students: prevalence and correlates from a national survey. Addict Behav. 2005;30:789–805.
McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs. 2006;38:43–56.
Franke AG, Konrad A, Lieb K, Huss M. Stimulant and non-stimulant medication in current and future therapy for ADHD. Fortschr Neurol Psychiatr. 2012;80(3):130–40.
Scholler G, Fliege H, Klapp BF. Questionnaire of self-efficacy, optimism and pessimism: reconstruction, selection of items and validation of an instrument by means of examinations of clinical samples. Psychother Psychosom Med Psychol. 1999;49:275–83.
Stasio MJ, Curry K, Sutton-Skinner KM, Glassman DM. Over-the-counter medication and herbal or dietary supplement use in college: dose frequency and relationship to self-reported distress. J Am Coll Health. 2008;56:535–47.
Arbour-Nicitopoulos KP, Kwan MY, Lowe D, Taman S, Faulkner GE. Social norms of alcohol, smoking, and marijuana use within a Canadian university setting. J Am Coll Health. 2011;59:191–6.
O’Cathail SM, O’Connell OJ, Long N, Morgan M, Eustace JA, et al. Association of cigarette smoking with drug use and risk taking behaviour in Irish teenagers. Addict Behav. 2011;36:547–50.
Stange R, Amhof R, Moebus S. Complementary and alternative medicine: attitudes and patterns of use by German physicians in a national survey. J Altern Complement Med. 2008;14:1255–61.
Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011;15:99–106.
Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, et al. Natural health product-drug interactions: a systematic review of clinical trials. Ther Drug Monit. 2005;27:549–57.
McCabe SE, Teter CJ, Boyd CJ. Illicit use of prescription pain medication among college students. Drug Alcohol Depend. 2005;77:37–47.
Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, et al. The misuse and diversion of prescribed ADHD medications by college students. J Atten Disord. 2009;13:144–53.
Barrett SP, Darredeau C, Bordy LE, Pihl RO. Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry. 2005;50:457–61.
Martin CS, Clifford PR, Clapper RL. Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students. J Subst Abuse. 1992;4:319–26.
Leao PB, Martins LA, Menezes PR, Bellodi PL. Well-being and help-seeking: an exploratory study among final-year medical students. Rev Assoc Med Bras. 2011;57:379–86.
Zinzow HM, Amstadter AB, McCauley JL, Ruggiero KJ, Resnick HS, et al. Self-rated health in relation to rape and mental health disorders in a national sample of college women. J Am Coll Health. 2011;59:588–94.
Lewis-Hall F. Gender differences in psychotropic medications. Mt Sinai J Med. 1996;63:326–9.
Fenton MC, Keyes KM, Martins SS, Hasin DS. The role of a prescription in anxiety medication use, abuse, and dependence. Am J Psychiatry. 2010;167:1247–53.
Blanco C, Alderson D, Ogburn E, Grant BF, Nunes EV, et al. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002. Drug Alcohol Depend. 2007;90:252–60.
Catalano RF, White HR, Fleming CB, Haggerty KP. Is nonmedical prescription opiate use a unique form of illicit drug use? Addict Behav. 2011;36:79–86.
Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci. 2011;8:73–96.
Perera B, Torabi M, Kay NS. Alcohol use, related problems and psychological health in college students. Int J Adolesc Med Health. 2011;23:33–7.
van Gelder MM, Reefhuis J, Herron AM, Williams ML, Roeleveld N. Reproductive health characteristics of marijuana and cocaine users: results from the 2002 National Survey of Family Growth. Perspect Sex Reprod Health. 2011;43:164–72.
Schmitter M, Liedl M, Beck J, et al. Chronic stress in medical and dental education. Medical teacher 2008;30:97–99.
Prinz P, Hertrich K, Hirschfelder U, et al. Burnout, depression and depersonalisation—psychological factors and coping strategies in dental and medical students. GMS Zeitschrift für medizinische Ausbildung 2012;29:Doc10.
Jurkat H, Hofer S, Richter L, Cramer M, Vetter A. Quality of life, stress management and health promotion in medical and dental students. A comparative study. Dtsch Med Wochenschr. 2011;136:1245–50.
Pejnovic Franelic I, Kuzman M, Pavic Simetin I, Kern J. Impact of environmental factors on marijuana use in 11 European countries. Croat Med J. 2011;52:446–57.
Kenna GA, Lewis DC. Risk factors for alcohol and other drug use by healthcare professionals. Subst Abuse Treat Prev Policy. 2008;3:3.
Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, et al. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings. Am J Drug Alcohol Abuse. 2011;37:301–12.
Toprak S, Cetin I, Akgul E, Can G. Factors associated with illicit drug abuse among Turkish college students. J Addict Med. 2011;4:93–8.
Schlimme JE. Addiction and self-determination: a phenomenological approach. Theor Med Bioeth. 2011;31:49–62.
Conrod PJ, Castellanos-Ryan N, Strang J. Brief, personality-targeted coping skills interventions and survival as a non-drug user over a 2-year period during adolescence. Arch Gen Psychiatry. 2011;67:85–93.
Conflict of interest
All authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mache, S., Eickenhorst, P., Vitzthum, K. et al. Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wien Med Wochenschr 162, 262–271 (2012). https://doi.org/10.1007/s10354-012-0115-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10354-012-0115-y